CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Quest Diagnostics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Quest Diagnostics Inc
500 Plaza Drive
Phone: (973) 520-2700p:973 520-2700 SECAUCUS, NJ  07094  United States Ticker: DGXDGX

Business Summary
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes-YesYes

Industries
SIC Code Description
8071 Medical laboratories

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, President, Chief Executive Officer James E.Davis 60 4/1/2023 4/16/2013
Chief Financial Officer, Executive Vice President Sam A.Samad 53 7/25/2022 7/11/2022
Senior Vice President, General Counsel Michael E.Prevoznik 61 8/1/2003 8/1/1999
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
HemoCue AB Box 1204 Sweden
Haystack Oncology GmbH Luruper Hauptstr, 1 Hamburg Germany
Celera Corporation 1401 Alameda CA United States
17 additional Subsidiary records available in full report.

Business Names
Business Name
American Medical Laboratories, Incorporated
AmeriPath Cincinnati, Inc.
AmeriPath Cleveland, Inc.
85 additional Business Names available in full report.

General Information
Number of Employees: 40,000 (As of 12/31/2023)
Outstanding Shares: 110,707,293 (As of 2/1/2024)
Shareholders: 2,110
Stock Exchange: NYSE
Federal Tax Id: 223471689
Fax Number: (302) 655-5049
Email Address: investor@questdiagnostics.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024